NCT02322580View on ClinicalTrials.gov

An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients

CompletedOBSERVATIONAL

Enrollment

56

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

November 30, 2016

Conditions

Psoriasis

Interventions

DRUG

etanercept

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02322580 - An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients | Biotech Hunter | Biotech Hunter